Pronóstico del mercado de modelos de hígado humano de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por tipo (organoides hepáticos, hígado en un chip, modelos 2D, bioimpresión 3D y otros), aplicación (descubrimiento de fármacos, educación y otros) ), y Usuario Final (Empresas Farmacéuticas y Biotecnológicas, Institutos de Investigación y Otros)

Se espera que el mercado de modelos de hígado humano de APAC crezca de 33.191,56 mil dólares en 2021 a 76.341,40 mil dólares en 2028; se estima que crecerá a una tasa compuesta anual del 12,6% de 2021 a 2028.\\n\\nChina, Japón, India, Corea del Sur y Australia son las principales economías de APAC. Se espera que un mayor enfoque en las actividades de descubrimiento de fármacos impulse el crecimiento del mercado. Antes de probar un nuevo fármaco en un estudio clínico, la fase principal de análisis de farmacodinámica y farmacocinética se lleva a cabo utilizando modelos animales y modelos in vitro bidimensionales (2D). Se necesitan 1.215 años y 35.000 millones de dólares para llevar un solo fármaco al mercado. La creciente demanda de medicamentos nuevos y avanzados está impulsando el ritmo general de descubrimiento y descubrimiento de fármacos. Como resultado, se están realizando un gran número de estudios clínicos para inventar y comercializar nuevos fármacos. Incluso después del lanzamiento al mercado (fase IV), todavía se producen muchas retiradas de medicamentos por motivos toxicológicos. Alrededor del 1.830% de estos retiros se deben a efectos hepatotóxicos, lo que demuestra que el hígado es el objetivo más común de las reacciones adversas a los medicamentos (RAM). El hígado desempeña un papel crucial en el metabolismo de los fármacos, la homeostasis corporal, la digestión y la excreción de sustancias tóxicas. En el caso del hígado, los modelos más simples para el descubrimiento de fármacos son fracciones subcelulares aisladas, como los microsomas, que contienen enzimas metabolizadoras de fármacos (EMD) o mitocondrias aisladas. Para permitir una alta sensibilidad y especificidad, los modelos celulares deben replicar procesos farmacológicos de orden superior [es decir, biotransformación, cinética de transporte, formación de metabolitos secundarios e interacciones farmacológicas (DDI)]. Los modelos de hígado humano se utilizan para evaluar el metabolismo y la toxicidad de compuestos químicos y fármacos, y para evaluar candidatos a fármacos en investigaciones sobre el cáncer y estudios genéticos. Se espera que el aumento significativo de los ensayos clínicos impulse la demanda de tecnologías médicas avanzadas, incluidos los modelos organoides, impulsando así el crecimiento del mercado de APAC.\\n\\nLa industria biofarmacéutica de APAC se ha visto perturbada durante algunos meses en 2020 durante el brote de COVID-19. . La pandemia de COVID-19 interrumpió los ensayos clínicos debido a las restricciones impuestas para controlar la propagación de la infección. Sin embargo, con la creciente demanda de productos para tratar la infección por COVID-19, las empresas biofarmacéuticas y farmacéuticas de India y China continuaron centrándose en actividades de investigación. Por ejemplo, en febrero de 2020, Vir Biotechnology (EE. UU.) se asoció con WuXi Biologics (China) para desarrollar anticuerpos monoclonales humanos para tratar las infecciones por COVID-19. Esta asociación implica desarrollo clínico, fabricación y comercialización, y WuXi Biologics será responsable del desarrollo de procesos y formulaciones y de la producción temprana para el desarrollo clínico. Además, las empresas de la región han suspendido sus actividades principales para centrarse en el desarrollo de la vacuna COVID-19. Por ejemplo, en marzo de 2020, la biotecnológica CRO Novotech (Australia) se asoció con Komipharm International (Corea del Sur) para realizar ensayos clínicos de Panaphix como posible tratamiento para la COVID-19. Las recientes restricciones impuestas por muchos países en respuesta al brote de COVID-19 han afectado la investigación clínica en curso. \\n\\nCon las nuevas características y tecnologías, los proveedores pueden atraer nuevos clientes y ampliar su presencia en los mercados emergentes. Es probable que este factor impulse el mercado de modelos de hígado humano de APAC. Se espera que el mercado de modelos de hígado humano de APAC crezca a una buena tasa compuesta anual durante el período de pronóstico. \\n\\nIngresos del mercado de modelos de hígado humano de APAC y pronóstico hasta 2028 (miles de dólares estadounidenses) \\n\\nSegmentación del mercado de modelos de hígado humano de APAC \\nMercado de modelos de hígado humano de APAC por tipo\\n- Organoides hepáticos\\n- Hígado en un chip \\n- Modelos 2D\\n- Bioimpresión 3D\\n- Otros\\nMercado de modelos de hígado humano APAC por aplicación\\n- Descubrimiento de fármacos\\n- Educativo\\n- Otros\\nMercado de modelos de hígado humano APAC por usuario final\\n- Farmacéutico y biotecnológico Empresas\\n- Institutos de investigación \\n- Otros \\nMercado de modelos de hígado humano de APAC, por país\\n- Japón \\n- China\\n- India\\n- Corea del Sur \\n- Australia\\n- Resto de APAC\\nHígado humano de APAC Mercado de modelos -Empresas mencionadas \\n- BioIVT\\n- CELLINK\\n- CYFUSE BIOMEDICAL KK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- THERMO FISHER SCIENTIFIC INC.\\n\\ norte

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Human Liver Models Market By Type
1.3.2 APAC Human Liver Models Market By Application
1.3.3 APAC Human Liver Models Market By End User
1.3.4 APAC Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Human Liver Models Market Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Liver Diseases
5.1.2 Growing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 High Costs of Liver Models
5.3 Market Opportunities
5.3.1 Increasing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Technology Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market APAC Analysis
6.1 APAC Human Liver Models Market Revenue Forecast and Analysis
7. APAC Human Liver Models Market Analysis By Type
7.1 Overview
7.2 APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. APAC Human Liver Models Market Analysis By Application
8.1 Overview
8.2 APAC Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. APAC Human Liver Models Market Analysis By End User
9.1 Overview
9.2 APAC Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. APAC Human Liver Models Market Country Analysis
10.1 APAC: Human Liver Models Market
10.1.1 Overview
10.1.2 APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.2 China: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.1.3 China: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.1.4 China: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.2 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.1 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.2 Japan: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.2.3 Japan: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.2.4 Japan: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.3 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.1 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.2 India: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.3.3 India: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.3.4 India: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.4 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.1 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.2 Australia: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.4.3 Australia: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.4.4 Australia: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.5 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.1 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.2 South Korea: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.5.3 South Korea: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.5.4 South Korea: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.6 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.1 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.2 Rest of APAC: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.6.3 Rest of APAC: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.6.4 Rest of APAC: Human Liver Models Market, by End User, 20192028 (USD Thousand)
11. Impact Of COVID-19 Pandemic on APAC Human Liver Models Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CYFUSE BIOMEDICAL K.K.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES
Table 1. APAC Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. China: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 3. China: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 4. China: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 5. Japan: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 6. Japan: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 7. Japan: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 8. India: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 9. India: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 10. India: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 11. Australia: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 12. Australia: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 13. Australia: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 14. South Korea: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 15. South Korea: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 16. South Korea: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 17. Rest of APAC: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 18. Rest of APAC: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 19. Rest of APAC: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms

LIST OF FIGURES
Figure 1. APAC Human Liver Models Market Segmentation
Figure 2. APAC Human Liver Models Market Segmentation, By Country
Figure 3. APAC Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Human Liver Models Market Revenue Forecast and Analysis
Figure 9. APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. APAC Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. APAC Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. APAC 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. APAC 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. APAC Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. APAC Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. APAC Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. APAC Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. APAC Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. APAC Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. APAC Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. APAC: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 27. India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 29. South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 30. Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 31. Impact of COVID-19 Pandemic in APAC Country Markets

1. BioIVT
2. CELLINK
3. CYFUSE BIOMEDICAL K.K.
4. Emulate, Inc.
5. InSphero
6. Kerafast
7. MIMETAS BV
8. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the APAC human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample